ClearNote Health to Showcase Power of 5hmC Signatures for Treatment Monitoring at AACR Conference on Pancreatic Cancer

SAN DIEGO — Sept. 16, 2026 — ClearNote Health, a company dedicated to improving early detection and monitoring for some of the deadliest cancers, today announced it will present new data for its Avantect® Pancreatic Cancer Test and its Virtuoso® platform at the American Association for Cancer Research (AACR) Conference on Pancreatic Cancer, taking place […] The post ClearNote Health to Showcase Power of 5hmC Signatures for Treatment Monitoring at AACR Conference on Pancreatic Cancer appeared first on ClearNote Health .